In NSCLC cell lines with intact ATM kinase signaling, AZD6738 potentiates the cytotoxicity of cisplatin and gemcitabine, while displaying potent synergy with cisplatin in ATM-deficient NSCLC cells [95]. The gene discussed is ATM; the disease is non-small cell lung carcinoma.